PubRank

S Katzav

Author PubWeight™ 31.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 1992 3.02
2 Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. Nature 1985 2.48
3 Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science 1993 2.10
4 Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res 1991 1.88
5 A functional T-cell receptor signaling pathway is required for p95vav activity. Mol Cell Biol 1995 1.88
6 Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties. Nature 1980 1.35
7 Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest 1981 1.34
8 Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein. Mol Cell Biol 1994 1.12
9 Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst 1981 0.99
10 Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells. J Natl Cancer Inst 1983 0.97
11 The products of the mcf-2 and vav proto-oncogenes and of the yeast gene cdc-24 share sequence similarities. Oncogene 1992 0.89
12 Immuno-selection in vivo of H-2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence. Int J Cancer 1984 0.88
13 Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product. Exp Hematol 1996 0.86
14 Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation. Oncogene 1998 0.86
15 Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation. FEBS Lett 2000 0.84
16 Immunogenetic control of metastasis formation by a methylcholanthrene-induced tumor (T10) in mice: differential expression of H-2 gene products. Transplant Proc 1981 0.83
17 Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties. J Natl Cancer Inst 1983 0.83
18 General anesthesia during excision of a mouse tumor accelerates postsurgical growth of metastases by suppression of natural killer cell activity. Isr J Med Sci 1986 0.82
19 Identification of the Drosophila melanogaster homologue of the mammalian signal transducer protein, Vav. FEBS Lett 2000 0.81
20 Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin. J Biol Chem 1995 0.81
21 The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2. Hum Genet 1990 0.81
22 Protection of thrombin receptor expression under hypoxia. J Biol Chem 2000 0.80
23 Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency. J Natl Cancer Inst 1985 0.78
24 Apoptosis of thymic lymphoma clones by thymic epithelial cells: a putative model for 'death by neglect'. Immunol Lett 1999 0.78
25 Interactions between the local tumor and its metastases. Cancer Metastasis Rev 1982 0.77
26 Selecting, accelerating and suppressing interactions between macrophages and tumor cells. Invasion Metastasis 1985 0.77
27 Membrane IgM of bovine lymphocytes. Vet Immunol Immunopathol 1982 0.76
28 Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes. J Immunogenet 1987 0.76
29 Studies on effector cell-target cell interactions in vitro by means of the quantitative immunoadherence technique. Adv Exp Med Biol 1976 0.75
30 Immunogenetic control of metastatic competence of cloned tumor cell populations. Symp Fundam Cancer Res 1983 0.75
31 The immunologic basis of the fetal-maternal relationship. Transplant Proc 1980 0.75
32 Somatic cell hybridization between bovine leukemia virus-infected lymphocytes and murine plasma cell tumors: cell fusion studies with bovine cells. Mol Immunol 1982 0.75
33 Class I MHC antigens of different subregions induce different IgG subclasses. J Immunol 1983 0.75